Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, Robert J.; Tannir, Nizar M.; McDermott, David F.; Arén Frontera, Osvaldo; Melichar, Bohuslav; Choueiri, Toni K.; Plimack, Elizabeth R.; Barthélémy, Philippe; Porta, Camillo; George, Saby; Powles, Thomas; Donskov, Frede; Neiman, Victoria; Kollmannsberger, Christian K.; Salman, Pamela; Gurney, Howard; Hawkins, Robert; Ravaud, Alain; Grimm, Marc-Oliver; Bracarda, Sergio; Barrios, Carlos H.; Tomita, Yoshihiko; Castellano, Daniel; Rini, Brian I.; Chen, Allen C.; Mekan, Sabeen; McHenry, M. Brent; Wind-Rotolo, Megan; Doan, Justin; Sharma, Padmanee; Hammers, Hans J.; Escudier, Bernard; Kellokumpu-Lehtinen, Pirkko-Liisa; for the CheckMate 214 Investigators (2018)
Motzer, Robert J.
Tannir, Nizar M.
McDermott, David F.
Arén Frontera, Osvaldo
Melichar, Bohuslav
Choueiri, Toni K.
Plimack, Elizabeth R.
Barthélémy, Philippe
Porta, Camillo
George, Saby
Powles, Thomas
Donskov, Frede
Neiman, Victoria
Kollmannsberger, Christian K.
Salman, Pamela
Gurney, Howard
Hawkins, Robert
Ravaud, Alain
Grimm, Marc-Oliver
Bracarda, Sergio
Barrios, Carlos H.
Tomita, Yoshihiko
Castellano, Daniel
Rini, Brian I.
Chen, Allen C.
Mekan, Sabeen
McHenry, M. Brent
Wind-Rotolo, Megan
Doan, Justin
Sharma, Padmanee
Hammers, Hans J.
Escudier, Bernard
Kellokumpu-Lehtinen, Pirkko-Liisa
for the CheckMate 214 Investigators
2018
New England Journal of Medicine 378 14
1277-1290
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.